Mounjaro in India: Availability, Cost, and Real Results (2026)

Editorial notice: This article is general educational content about prescription weight-management treatments available in India. It is not medical advice, not a recommendation to use any specific medication, and not a promotion of any brand. NuvaHealth does not sell, stock, or dispense any medication. All treatment decisions must be made in a private consultation with a qualified doctor who has reviewed your complete medical history. Prescription medicines discussed here are Schedule H drugs and are available only with a valid prescription from a licensed pharmacy.

What Is Mounjaro?

Mounjaro is the brand name for tirzepatide, a once-weekly injectable medication made by Eli Lilly. It belongs to the family of treatments known as incretin therapies, but it is the first of its kind in one important way: it is a dual agonist, activating two gut-hormone receptors — GIP and GLP-1 — rather than one.

Most weight-loss injections people have heard of, including semaglutide (Ozempic, Wegovy), act on the GLP-1 receptor alone. Tirzepatide adds a second pathway. The practical result, seen consistently across clinical trials, is that it tends to produce greater average weight loss than single-pathway GLP-1 drugs. It is approved for both type 2 diabetes and chronic weight management.

Is Mounjaro Available in India?

Yes. Mounjaro launched in India in March 2025, making India one of the markets where tirzepatide is officially approved and available — not something patients have to import. It is sold on prescription in two formats:

• Vials — a small bottle of the medication, drawn up with a syringe.
• KwikPens — pre-filled injection pens, more convenient to use, available across the dose range.

Because it is a Schedule H prescription drug, Mounjaro can only be dispensed by a licensed pharmacy against a valid prescription. It cannot legitimately be bought over the counter, and it should never be purchased from unverified online sellers — counterfeit tirzepatide is a known and dangerous problem worldwide.

How Much Does Mounjaro Cost in India?

Mounjaro's price depends on the dose. As of 2026, approximate monthly costs in India are:

• 2.5 mg, the starting dose — around Rs 13,000 to Rs 14,000 per month
• 5 mg — around Rs 16,000 per month
• Higher doses, up to 15 mg — up to roughly Rs 26,000 per month

Vials are generally less expensive than KwikPens. Two points matter for budgeting. First, treatment starts low and increases gradually, so the early months usually cost less than later ones. Second, this is an ongoing treatment, not a one-month course — the cost should be considered as a sustained monthly commitment. Generic tirzepatide is expected in India around 2027 to 2028, which may reduce prices substantially, but that is not yet available.

How Mounjaro Is Taken

Mounjaro is a once-weekly subcutaneous injection — given under the skin of the abdomen, thigh or upper arm, on the same day each week. It comes in six dose strengths, from 2.5 mg to 15 mg.

Treatment always begins at the lowest dose of 2.5 mg, which is considered a starting dose rather than a treatment dose. The dose is then escalated gradually, typically every four weeks, under a doctor's guidance. This slow escalation is not bureaucratic caution — it is the single most important factor in reducing side effects, because it lets the body adjust.

What Results Can You Expect?

The clinical-trial evidence for tirzepatide is among the strongest ever recorded for a weight-management medication. In the landmark SURMOUNT-1 trial, participants on the 15 mg dose lost an average of around 21% of their body weight over 72 weeks. In the SURMOUNT-5 head-to-head trial, tirzepatide produced roughly 20.2% weight loss compared with 13.7% for semaglutide.

For an Indian adult weighing 95 kg, an average response in that range would mean roughly 18 to 20 kg of weight loss — achieved while eating normal meals rather than crash dieting. Two honest caveats apply: these are averages, and individual results vary widely; and the results were achieved with lifestyle support and supervision, not by the injection alone. Weight regain is common if the medication is stopped without a maintenance plan.

Side Effects and Safety

The most common side effects of Mounjaro are gastrointestinal: nausea, constipation, diarrhoea, reduced appetite and indigestion. These are usually mild to moderate, are worst in the first weeks and after each dose increase, and tend to settle. Slow dose escalation and simple dietary measures manage most of them.

More serious but less common risks include pancreatitis and gallbladder problems. Mounjaro carries a warning against use by anyone with a personal or family history of medullary thyroid carcinoma or the MEN-2 syndrome. Like all GLP-1-based drugs, it can also cause loss of muscle along with fat — which makes adequate protein intake and strength training important. Our dedicated guide covers GLP-1 side effects and how to manage them in full.

Who Should — and Should Not — Consider Mounjaro

Mounjaro is intended for people with obesity, or significant overweight accompanied by weight-related health conditions — not for cosmetic or modest weight loss. It is not appropriate for people who are pregnant or breastfeeding, those with a history of medullary thyroid cancer or pancreatitis, or those seeking a quick fix without medical supervision. Eligibility is a clinical judgement — our guide to who qualifies for GLP-1 medication explains the criteria, and the Indian-specific thresholds in our BMI guide are relevant here.

How to Start Safely

If you are considering Mounjaro, the correct first step is not a pharmacy — it is a doctor. A proper assessment covers your BMI and waist measurement, medical history, current medicines, blood tests and your goals, and only then determines whether tirzepatide is appropriate, at what dose, and with what monitoring. Starting without that assessment is how people end up with avoidable side effects, counterfeit product, or a treatment that was never right for them.

Get a Mounjaro Assessment on NuvaHealth

NuvaHealth connects you with licensed Indian doctors who can assess whether tirzepatide, or any other approach, suits your situation — through a private video consultation, with proper history-taking and follow-up, not a rushed sign-off.

Start your assessment on NuvaHealth today and find out, from a qualified doctor, whether Mounjaro has a place in your plan.